Trending News
-
Powell Signals Possible September Rate Cut, Markets React
Federal Reserve Chair Jerome Powell just opened the door for a potential rate cut in…
Read More » -
-
-
-
-
-
-
-
Tech
-
Company
Intel’s Last Stand: Why The U.S. Government May Take A Stake In The Struggling Chip Giant
Intel, once the undisputed titan of the global semiconductor industry, now finds itself at the complex crossroads of policy, geopolitics,…
Read More » -
Company
Google Bets on AI and Innovation in New Pixel 10 Smartphones, Including Foldable Model
Google has officially launched its latest Pixel phones, debuting four new devices at its “Made By Google” event in New…
Read More » -
Company
Alphabet’s Legal Nightmare: Will Google Chrome Become The DOJ’s First Target?
Alphabet has recently found itself under intensifying scrutiny as U.S. regulators pursue drastic antitrust remedies following its most recent court…
Read More »
Biotech
-
Biotech
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the…
Read More » -
Biotech
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
BioNTech’s recent $1.25 billion all-stock acquisition of former rival CureVac marks a definitive shift in strategy—away from COVID-19 vaccine reliance…
Read More » -
Biotech
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
Bristol Myers has inked a transformative partnership for BNT327, a bispecific PD-L1/VEGF-A antibody developed by BioNTech, with a $1.5 billion…
Read More »
Healthcare
-
Company
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share,…
Read More » -
Company
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion…
Read More » -
Company
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
DexCom has undergone a major strategic reset after a turbulent 2024, and all eyes are now on its bold shift…
Read More »
-
Cannabis
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants…
Read More » -
-
-
Follow us on Twitter